Role of cardiolipin alterations in mitochondrial dysfunction and disease

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 1, 2007, Pages

  Chicco, Adam J ^a   Sparagna, Genevieve C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Aging; Diet; Heart failure; Hypothyroidism; Ischemia; Lipid peroxidation; Metabolism; Oxidative stress; Phospholipid

Indexed keywords

CARDIOLIPIN;

AGING; ALCOHOL CONSUMPTION; BARTH SYNDROME; BIOENERGY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; HEART FAILURE; HUMAN; HYPOTHYROIDISM; ISCHEMIA; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; NUTRITIONAL DEFICIENCY; PEROXIDATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

AGING; ANIMALS; CARDIAC OUTPUT, LOW; CARDIOLIPINS; CARDIOMYOPATHY, DILATED; DISEASE; GENETIC DISEASES, X-LINKED; HUMANS; HYPOTHYROIDISM; ISCHEMIA; MITOCHONDRIA; SYNDROME;

EID: 33846272138     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00243.2006     Document Type: Review

References (192)

1. Adibhatla RM, Hatcher JF, Dempsey RJ. Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid Redox Signal 5: 647-654, 2003.
2. 1H-NMR. Biochim Biophys Acta 1299: 167-174, 1996.
3. Ames BN, Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann NY Acad Sci 1033: 108-116, 2004.
4. Ames BN, Shigenaga MK, Hagen TM. Mitochondrial decay in aging. Biochim Biophys Acta 1271: 165-170, 1995.
5. Barth PG, Valianpour F, Bowen VM, Lam J, Duran M, Vaz FM, Wanders RJ. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet 126: 349-354, 2004.
6. Barth PG, Van den Bogert C, Bolhuis PA, Scholte HR, van Gennip AH, Schutgens RB, Ketel AG. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts. J Inherit Metab Dis 19: 157-160, 1996.
7. Barth PG, Wanders RJ, Vreken P. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060. J Pediatr 135: 273-276, 1999.
8. Beal MF. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann NY Acad Sci 991: 120-131, 2003.
9. Beleznai Z, Jancsik V. Role of cardiolipin in the functioning of mitochondrial L-glycerol-3-phosphate dehydrogenase. Biochem Biophys Res Commun 159: 132-139, 1989.
10. Berger A, German JB, Gershwin ME. Biochemistry of cardiolipin: sensitivity to dietary fatty acids. Adv Food Nutr Res 37: 259-338, 1993.
11. Beyer K, Nuscher B. Specific cardiolipin binding interferes with labeling of sulfhydryl residues in the adenosine diphosphate/adenosine triphosphate carrier protein from beef heart mitochondria. Biochemistry 35: 15784-15790, 1996.
12. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D. A novel X-linked gene, G4.5 is responsible for Barth syndrome. Nat Genet 12: 385-389, 1996.
13. Brandner K, Mick DU, Frazier AE, Taylor RD, Meisinger C, Rehling P. Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth syndrome. Mol Biol Cell 16: 5202-5214, 2005.
14. Brandt MA, Powers-Lee SG. The interaction of cardiolipin with rat liver carbamoyl phosphate synthetase I. Arch Biochem Biophys 290: 14-20, 1991.
15. Buckland AG, Kinkaid AR, Wilton DC. Cardiolipin hydrolysis by human phospholipases A2. The multiple enzymatic activities of human cytosolic phospholipase A2. Biochim Biophys Acta 1390: 65-72, 1998.
16. Cao SG, Cheng P, Angel A, Hatch GM. Thyroxine stimulates phosphatidylglycerolphosphate synthase activity in rat heart mitochondria. Biochim Biophys Acta 1256: 241-244, 1995.
17. Castro J, Cortes JP, Guzman M. Properties of the mitochondrial membrane and carnitine palmitoyltransferase in the periportal and the perivenous zone of the liver. Effects of chronic ethanol feeding. Biochem Pharmacol 41: 1987-1995, 1991.
18. Cheng P, Hatch GM. Inhibition of cardiolipin biosynthesis in the hypoxic rat heart. Lipids 30: 513-519, 1995.
19. Chi Y, Gupta RK. Alterations in heart and kidney membrane phospholipids in hypertension as observed by 31P nuclear magnetic resonance. Lipids 33: 1023-1030, 1998.
20. Cunningham CC, Spach PI. The effect of chronic ethanol consumption on the lipids in liver mitochondria. Ann NY Acad Sci 492: 181-192, 1987.
21. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822, 2003.
22. De Schrijver R, Vermeulen D. Separation and quantitation of phospholipids in animal tissues by Iatroscan TLC/FID. Lipids 26: 74-76, 1991.
23. De Windt LJ, Reneman RS, Van der Vusse GJ, Van Bilsen M. Phospholipase A2-mediated hydrolysis of cardiac phospholipids: the use of molecular and transgenic techniques. Mol Cell Biochem 180: 65-73, 1998.
24. de Winter JM, Lenting HB, Neys FW, van den Bosch H. Hydrolysis of membrane-associated phosphoglycerides by mitochondrial phospholipase A2. Biochim Biophys Acta 917: 169-177, 1987.
25. Eble KS, Coleman WB, Hantgan RR, Cunningham CC. Tightly associated cardiolipin in the bovine heart mitochondrial ATP synthase as analyzed by 31P nuclear magnetic resonance spectroscopy. J Biol Chem 265: 19434-19440, 1990.
26. Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcelo-Coblijn GC, Nussbaum RL. Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein. Mol Cell Biol 25: 10190-10201, 2005.
27. Enns GM. The contribution of mitochondria to common disorders. Mol Genet Metab 80: 11-26, 2003.
28. Erbrich U, Naujok A, Petschel K, Zimmermann HW. [The fluorescent staining of mitochondria in living HeLa- and LM-cells with new acridine dyes (author's transl)]. Histochemistry 74: 1-7, 1982.
29. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S. Role of mitochondria in toxic oxidative stress. Mol Interv 5: 94-111, 2005.
30. Ferreira FM, Seica R, Oliveira PJ, Coxito PM, Moreno AJ, Palmeira CM, Santos MS. Diabetes induces metabolic adaptations in rat liver mitochondria: role of coenzyme Q and cardiolipin contents. Biochim Biophys Acta 1639: 113-120, 2003.
31. Fry M, Green DE. Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. Biochem Biophys Res Commun 93: 1238-1246, 1980.
32. Fry M, Green DE. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. J Biol Chem 256: 1874-1880, 1981.
33. Garcia Fernandez MI, Ceccarelli D, Muscatello U. Use of the fluorescent dye 10-N-nonyl acridine orange in quantitative and location assays of cardiolipin: a study on different experimental models. Anal Biochem 328: 174-180, 2004.
34. Gomez B Jr. and Robinson NC. Phospholipase digestion of bound cardiolipin reversibly inactivates bovine cytochrome bc1. Biochemistry 38: 9031-9038, 1999.
35. Gomez B Jr. and Robinson NC. Quantitative determination of cardiolipin in mitochondrial electron transferring complexes by silicic acid high-performance liquid chromatography. Anal Biochem 267: 212-216, 1999.
36. Gredilla R, Lopez Torres M, Portero-Otin M, Pamplona R, Barja G. Influence of hyper- and hypothyroidism on lipid peroxidation, unsaturation of phospholipids, glutathione system and oxidative damage to nuclear and mitochondrial DNA in mice skeletal muscle. Mol Cell Biochem 221: 41-48, 2001.
37. Guan Z, Grunler J, Piao S, Sindelar PJ. Separation and quantitation of phospholipids and their ether analogues by high-performance liquid chromatography. Anal Biochem 297: 137-143, 2001.
38. Guan ZZ, Soderberg M, Sindelar P, Edlund C. Content and fatty acid composition of cardiolipin in the brain of patients with Alzheimer's disease. Neurochem Int 25: 295-300, 1994.
39. Gudbjarnason S, el-Hage AN, Whitehurst VE, Simental F, Balazs T. Reduced arachidonic acid levels in major phospholipids of heart muscle in the diabetic rat. J Mol Cell Cardiol 19: 1141-1146, 1987.
40. Haddadian E, Shamsi SA, Schaeper JP, Danielson ND. Capillary electrophoresis of phospholipids with indirect photometric detection. J Chromatogr Sci 36: 395-400, 1998.
41. Hagen TM, Ingersoll RT, Wehr CM, Lykkesfeldt J, Vinarsky V, Bartholomew JC, Song MH, Ames BN. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc Natl Acad Sci USA 95: 9562-9566, 1998.
42. Haines TH, Dencher NA. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett 528: 35-39, 2002.
43. Han X, Yang K, Yang J, Cheng H, Gross RW. Shotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samples. J Lipid Res 47: 864-879, 2006.
44. Hatch GM. Cardiolipin: biosynthesis, remodeling and trafficking in the heart and mammalian cells (Review). Int J Mol Med 1: 33-41, 1998.
45. Hatch GM, Cao SG, Angel A. Decrease in cardiac phosphatidylglycerol in streptozotocin-induced diabetic rats does not affect cardiolipin biosynthesis: evidence for distinct pools of phosphatidylglycerol in the heart. Biochem J 306: 759-764, 1995.
46. Hatch GM, McClarty G. Regulation of cardiolipin biosynthesis in H9c2 cardiac myoblasts by cytidine 5′-triphosphate. J Biol Chem 271: 25810-25816, 1996.
47. Hauff KD, Hatch GM. Cardiolipin metabolism and Barth syndrome. Prog Lipid Res, 2006.
48. Heerdt PM, Schlame M, Jehle R, Barbone A, Burkhoff D, Blanck TJ. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg 73: 1216-1221, 2002.
49. Helmy FM, Hack MH, Juracka A. Age-related changes of the endogenous cardiolipin and plasmalogens of guinea pig kidney and their in vitro hydrolysis by endogenous phospholipases: a thin layer chromatographic analysis in conjunction with densitometric measurement. Cell Biochem Funct 21: 337-344, 2003.
50. Helmy FM, Hassanein M, Juracka A. Studies on the endogenous phospholipids of mammalian kidney and their in vitro hydrolysis by endogenous phospholipases: a thin layer chromatographic and densitometric study. Cell Biochem Funct 22: 379-387, 2004.
51. 3H]arachidonic and [14C]linoleic acid in essential fatty acid-deficient rats. Am J Physiol Gastrointest Liver Physiol 259: G116-G124, 1990.
52. Hoch FL. Cardiolipins and biomembrane function. Biochim Biophys Acta 1113: 71-133, 1992.
53. Hoch FL. Cardiolipins and mitochondrial proton-selective leakage. J Bioenerg Biomembr 30: 511-532, 1998.
54. Hoch FL. Lipids and thyroid hormones. Prog Lipid Res 27: 199-270, 1988.
55. Honda K, Casadesus G, Petersen RB, Perry G, Smith MA. Oxidative stress and redox-active iron in Alzheimer's disease. Ann NY Acad Sci 1012: 179-182, 2004.
56. Hoppel CL, Moghaddas S, Lesnefsky EJ. Interfibrillar cardiac mitochondrial complex III defects in the aging rat heart. Biogerontology 3: 41-44, 2002.
57. Hoppel CL, Tandler B, Parland W, Turkaly JS, Albers LD. Hamster cardiomyopathy. A defect in oxidative phosphorylation in the cardiac interfibrillar mitochondria. J Biol Chem 257: 1540-1548, 1982.
58. Hostetler KY. Effect of thyroxine on the activity of mitochondrial cardiolipin synthase in rat liver. Biochim Biophys Acta 1086: 139-140, 1991.
59. Hostetler KY, Galesloot JM, Boer P, Van Den Bosch H. Further studies on the formation of cardiolipin and phosphatidylglycerol in rat liver mitochondria. Effect of divalent cations and the fatty acid composition of CDP-diglyceride. Biochim Biophys Acta 380: 382-389, 1975.
60. Hostetler KY, Zenner BD, Morris HP. Altered subcellular and submitochondrial localization of CTP:phosphatidate cytidylyltransferase in the Morris 7777 hepatoma. J Lipid Res 19: 553-560, 1978.
61. Hsu FF, Turk J, Rhoades ER, Russell DG, Shi Y, Groisman EA. Structural characterization of cardiolipin by tandem quadrupole and multiple-stage quadrupole ion-trap mass spectrometry with electrospray ionization. J Am Soc Mass Spectrom 16: 491-504, 2005.
62. Indiveri C, Tonazzi A, Prezioso G, Palmieri F. Kinetic characterization of the reconstituted carnitine carrier from rat liver mitochondria. Biochim Biophys Acta 1065: 231-238, 1991.
63. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95: 135-145, 2004.
64. Jacobson J, Duchen MR, Heales SJ. Intracellular distribution of the fluorescent dye nonyl acridine orange responds to the mitochondrial membrane potential: implications for assays of cardiolipin and mitochondrial mass. J Neurochem 82: 224-233, 2002.
65. Jenner P. Oxidative stress as a cause of Parkinson's disease. Acta Neurol Scand Suppl 136: 6-15, 1991.
66. Kadenbach B, Mende P, Kolbe HV, Stipani I, Palmieri F. The mitochondrial phosphate carrier has an essential requirement for cardiolipin. FEBS Lett 139: 109-112, 1982.
67. Keenan TW, Awasthi YC, Crane FL. Cardiolipin from beef heart mitochondria: fatty acid positioning an molecular species distribution. Biochem Biophys Res Commun 40: 1102-1109, 1970.
68. Keij JF, Bell-Prince C, Steinkamp JA. Staining of mitochondrial membranes with 10-nonyl acridine orange, MitoFluor Green, and Mito-Tracker Green is affected by mitochondrial membrane potential altering drugs. Cytometry 39: 203-210, 2000.
69. Koekemoer TC, Oelofsen W. Properties of porcine white adipose tissue and liver mitochondrial subpopulations. Int J Biochem Cell Biol 33: 889-901, 2001.
70. Korytowski W, Niziolek M, Girotti AW. Separation and quantitation of phospholipid hydroperoxide families using high-performance liquid chromatography with mercury cathode electrochemical detection. Anal Biochem 343: 136-142, 2005.
71. Koshkin V, Greenberg ML. Cardiolipin prevents rate-dependent uncoupling and provides osmotic stability in yeast mitochondria. Biochem J 364: 317-322, 2002.
72. Kriska T, Girotti AW. Separation and quantitation of peroxidized phospholipids using high-performance thin-layer chromatography with tetramethyl-p-phenylenediamine detection. Anal Biochem 327: 97-106, 2004.
73. Laganiere S, Yu BP. Modulation of membrane phospholipid fatty acid composition by age and food restriction. Gerontology 39: 7-18, 1993.
74. Lagerwall K, Madhu B, Daneryd P, Schersten T, Soussi B. Purine nucleotides and phospholipids in ischemic and reperfused rat skeletal muscle: effect of ascorbate. Am J Physiol Heart Circ Physiol 272: H83-H90, 1997.
75. Lambeth JD. Cytochrome P450scc cardiolipin as an effector of activity of a mitochondrial cytochrome P-450. J Biol Chem 256: 4757-4762, 1981.
76. Lange C, Nett JH, Trumpower BL, Hunte C. Specific roles of protein-phospholipid interactions in the yeast cytochrome bc1 complex structure. EMBO J 20: 6591-6600, 2001.
77. Lee HJ, Mayette J, Rapoport SI, Bazinet RP. Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis 5: 2, 2006.
78. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 279: 47961-47967, 2004.
79. Lesnefsky EJ, Chen Q, Slabe TJ, Stoll MS, Minkler PE, Hassan MO, Tandler B, Hoppel CL. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol 287: H258-H267, 2004.
80. Lesnefsky EJ, Slabe TJ, Stoll MS, Minkler PE, Hoppel CL. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 280: H2770-H2778, 2001.
81. Lesnefsky EJ, Stoll MS, Minkler PE, Hoppel CL. Separation and quantitation of phospholipids and lysophospholipids by high-performance liquid chromatography. Anal Biochem 285: 246-254, 2000.
82. Lewin MB, Timiras PS. Lipid changes with aging in cardiac mitochondrial membranes. Mech Ageing Dev 24: 343-351, 1984.
83. Lipman RD, Chrisp CE, Hazzard DG, Bronson RT. Pathologic characterization of brown Norway, brown Norway x Fischer 344, and Fischer 344 x brown Norway rats with relation to age. J Gerontol A Biol Sci Med Sci 51: B54-59, 1996.
84. Ma BJ, Taylor WA, Dolinsky VW, Hatch GM. Acylation of monolysocardiolipin in rat heart. J Lipid Res 40: 1837-1845, 1999.
85. Ma L, Vaz FM, Gu Z, Wanders RJ, Greenberg ML. The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Δ mutant. Implications for Barth syndrome. J Biol Chem 279: 44394-44399, 2004.
86. Maftah A, Ratinaud MH, Dumas M, Bonte F, Meybeck A, Julien R. Human epidermal cells progressively lose their cardiolipins during ageing without change in mitochondrial transmembrane potential. Mech Ageing Dev 77: 83-96, 1994.
87. McGee CD, Lieberman P, Greenwood CE. Dietary fatty acid composition induces comparable changes in cardiolipin fatty acid profile of heart and brain mitochondria. Lipids 31: 611-616, 1996.
88. McLean LR, Hagaman KA, Davidson WS. Role of lipid structure in the activation of phospholipase A2 by peroxidized phospholipids. Lipids 28: 505-509, 1993.
89. McMillin JB, Dowhan W. Cardiolipin and apoptosis. Biochim Biophys Acta 1585: 97-107, 2002.
90. Metz KR, Dunphy LK. Absolute quantitation of tissue phospholipids using 31P NMR spectroscopy. J Lipid Res 37: 2251-2265, 1996.
91. Mileykovskaya E, Zhang M, Dowhan W. Cardiolipin in energy transducing membranes. Biochemistry (Mosc) 70: 154-158, 2005.
92. Moghaddas S, Stoll MS, Minkler PE, Salomon RG, Hoppel CL, Lesnefsky EJ. Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria. J Gerontol A Biol Sci Med Sci 57: B22-28, 2002.
93. Moreira PI, Santos MS, Moreno AM, Proenca T, Seica R, Oliveira CR. Effect of streptozotocin-induced diabetes on rat brain mitochondria. J Neuroendocrinol 16: 32-38, 2004.
94. Muller M, Cheneval D, Carafoli E. The mitochondrial creatine phosphokinase is associated with inner membrane cardiolipin. Adv Exp Med Biol 194: 151-156, 1986.
95. Musatov A. Contribution of peroxidized cardiolipin to inactivation of bovine heart cytochrome c oxidase. Free Radic Biol Med 41: 238-246, 2006.
96. Mutter T, Dolinsky VW, Ma BJ, Taylor WA, Hatch GM. Thyroxine regulation of monolysocardiolipin acyltransferase activity in rat heart. Biochem J 346: 403-406, 2000.
97. Nakahara I, Kikuchi H, Taki W, Nishi S, Kito M, Yonekawa Y, Goto Y, Ogata N. Changes in major phospholipids of mitochondria during postischemic reperfusion in rat brain. J Neurosurg 76: 244-250, 1992.
98. Nalecz KA, Bolli R, Wojtczak L, Azzi A. The monocarboxylate carrier from bovine heart mitochondria: partial purification and its substratetransporting properties in a reconstituted system. Biochim Biophys Acta 851: 29-37, 1986.
99. Noel H, Pande SV. An essential requirement of cardiolipin for mitochondrial carnitine acylcarnitine translocase activity. Lipid requirement of carnitine acylcarnitine translocase. Eur J Biochem 155: 99-102, 1986.
100. O'Brien PJ. Intracellular mechanisms for the decomposition of a lipid peroxide. I. Decomposition of a lipid peroxide by metal ions, heme compounds, and nucleophiles. Can J Biochem 47: 485-492, 1969.
101. Okayasu T, Curtis MT, Farber JL. Structural alterations of the inner mitochondrial membrane in ischemic liver cell injury. Arch Biochem Biophys 236: 638-645, 1985.
102. Okumura K, Yamada Y, Kondo J, Hashimoto H, Ito T, Kitoh J. Decreased 1,2-diacylglycerol levels in myopathic hamster hearts during the development of heart failure. J Mol Cell Cardiol 23: 409-416, 1991.
103. O'Rourke B, Reibel DK. Effects of adrenoceptor blockade on cardiac hypertrophy and myocardial phospholipids. Proc Soc Exp Biol Med 200: 95-100, 1992.
104. Ostrander DB, Sparagna GC, Amoscato AA, McMillin JB, Dowhan W. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J Biol Chem 276: 38061-38067, 2001.
105. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 99: 1259-1263, 2002.
106. Padma P, Setty OH. Protective effect of Phyllanthus fraternus against carbon tetrachloride-induced mitochondrial dysfunction. Life Sci 64: 2411-2417, 1999.
107. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252: 8731-8739, 1977.
108. Pangborn M. Isolation and purification of a serologically active phospholipid from beef heart. J Biol Chem 143: 247-256, 1942.
109. Pangborn M. A new serologically active phospholipid from beef heart. Proc Soc Exp Biol Med 48: 484-486, 1941.
110. Pangborn M. A simplified preparation of cardiolipin, with a note on purification of lecithin for serologic use. J Biol Chem 161: 71-82, 1945.
111. Paradies G, Petrosillo G, Gadaleta MN, Ruggiero FM. The effect of aging and acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria. FEBS Lett 454: 207-209, 1999.
112. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A, Ruggiero FM. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res 94: 53-59, 2004.
113. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Serena D, Ruggiero FM. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic Biol Med 27: 42-50, 1999.
114. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett 466: 323-326, 2000.
115. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 286: 135-141, 2002.
116. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles. Mitochondrion 1: 151-159, 2001.
117. Paradies G, Petrosillo G, Ruggiero FM. Cardiolipin-dependent decrease of cytochrome c oxidase activity in heart mitochondria from hypothyroid rats. Biochim Biophys Acta 1319: 5-8, 1997.
118. Paradies G, Ruggiero FM. Effect of hyperthyroidism on the transport of pyruvate in rat-heart mitochondria. Biochim Biophys Acta 935: 79-86, 1988.
119. Paradies G, Ruggiero FM. Stimulation of phosphate transport in ratliver mitochondria by thyroid hormones. Biochim Biophys Acta 1019: 133-136, 1990.
120. Paradies G, Ruggiero FM, Dinoi P. The influence of hypothyroidism on the transport of phosphate and on the lipid composition in rat-liver mitochondria. Biochim Biophys Acta 1070: 180-186, 1991.
121. Paradies G, Ruggiero FM, Dinoi P, Petrosillo G, Quagliariello E. Decreased cytochrome oxidase activity and changes in phospholipids in heart mitochondria from hypothyroid rats. Arch Biochem Biophys 307: 91-95, 1993.
122. Paradies G, Ruggiero FM, Gadaleta MN, Quagliariello E. The effect of aging and acetyl-L-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria. Biochim Biophys Acta 1103: 324-326, 1992.
123. Paradies G, Ruggiero FM, Petrosillo G, Gadaleta MN, Quagliariello E. Carnitine-acylcarnitine translocase activity in cardiac mitochondria from aged rats: the effect of acetyl-L-carnitine. Mech Ageing Dev 84: 103-112, 1995.
124. Paradies G, Ruggiero FM, Petrosillo G, Gadaleta MN, Quagliariello E. Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett 350: 213-215, 1994.
125. Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E. Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: role of cardiolipin. FEBS Lett 406: 136-138, 1997.
126. Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E. Alterations in carnitine-acylcarnitine translocase activity and in phospholipid composition in heart mitochondria from hypothyroid rats. Biochim Biophys Acta 1362: 193-200, 1997.
127. Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E. Enhanced cytochrome oxidase activity and modification of lipids in heart mitochondria from hyperthyroid rats. Biochim Biophys Acta 1225: 165-170, 1994.
128. Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E. Peroxidative damage to cardiac mitochondria: cytochrome oxidase and cardiolipin alterations. FEBS Lett 424: 155-158, 1998.
129. Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E. Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid rats. FEBS Lett 397: 260-262, 1996.
130. Pehowich DJ. Hypothyroid state and membrane fatty acid composition influence cardiac mitochondrial pyruvate oxidation. Biochim Biophys Acta 1235: 231-238, 1995.
131. Pember SO, Powell GL, Lambeth JD. Cytochrome P450scc-phospholipid interactions. Evidence for a cardiolipin binding site and thermodynamics of enzyme interactions with cardiolipin, cholesterol, and adrenodoxin. J Biol Chem 258: 3198-3206, 1983.
132. 2+ activation of PDH. Am J Physiol Heart Circ Physiol 276: H149-H158, 1999.
133. Petit JM, Maftah A, Ratinaud MH, Julien R. 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem 209: 267-273, 1992.
134. Petrosillo G, Di Venosa N, Pistolese M, Casanova G, Tiravanti E, Colantuono G, Federici A, Paradies G, Ruggiero FM. Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia-reperfusion: role of cardiolipin. FASEB J 20: 269-276, 2006.
135. Petrosillo G, Di Venosa N, Ruggiero FM, Pistolese M, D'Agostino D, Tiravanti E, Fiore T, Paradies G. Mitochondrial dysfunction associated with cardiac ischemia/reperfusion can be attenuated by oxygen tension control. Role of oxygen-free radicals and cardiolipin. Biochim Biophys Acta 1710: 78-86, 2005.
136. Petrosillo G, Ruggiero FM, Di Venosa N, Paradies G. Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J 17: 714-716, 2003.
137. Petrosillo G, Ruggiero FM, Pistolese M, Paradies G. Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef-heart submitochondrial particles via cardiolipin peroxidation. Possible role in the apoptosis. FEBS Lett 509: 435-438, 2001.
138. Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML, Schagger H. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 278: 52873-52880, 2003.
139. Poorthuis BJ, Yazaki PJ, Hostetler KY. An improved two dimensional thin-layer chromatography system for the separation of phosphatidylglycerol and its derivatives. J Lipid Res 17: 433-437, 1976.
140. Powell GL, Jacobus J. The nonequivalence of the phosphorus atoms in cardiolipin. Biochemistry 13: 4024-4026, 1974.
141. Power GW, Yaqoob P, Harvey DJ, Newsholme EA, Calder PC. The effect of dietary lipid manipulation on hepatic mitochondrial phospholipid fatty acid composition and carnitine palmitoyltransferase I activity. Biochem Mol Biol Int 34: 671-684, 1994.
142. Pulfer M, Murphy RC. Electrospray mass spectrometry of phospholipids. Mass Spectrom Rev 22: 332-364, 2003.
143. Qi L, Danielson ND, Dai Q, Lee RM. Capillary electrophoresis of cardiolipin with on-line dye interaction and spectrophotometric detection. Electrophoresis 24: 1680-1686, 2003.
144. Reibel DK, O'Rourke B, Foster KA, Hutchinson H, Uboh CE, Kent RL. Altered phospholipid metabolism in pressure-overload hypertrophied hearts. Am J Physiol Heart Circ Physiol 250: H1-H6, 1986.
145. Ritov VB, Menshikova EV, Kelley DE. Analysis of cardiolipin in human muscle biopsy. J Chromatogr A 831: 63-71, 2006.
146. Robinson NC. Functional binding of cardiolipin to cytochrome c oxidase. J Bioenerg Biomembr 25: 153-163, 1993.
147. Ruggiero FM, Cafagna F, Petruzzella V, Gadaleta MN, Quagliariello E. Lipid composition in synaptic and nonsynaptic mitochondria from rat brains and effect of aging. J Neurochem 59: 487-491, 1992.
148. Ruggiero FM, Landriscina C, Gnoni GV, Quagliariello E. Lipid composition of liver mitochondria and microsomes in hyperthyroid rats. Lipids 19: 171-178, 1984.
149. Rustow B, Schlame M, Rabe H, Reichmann G, Kunze D. Species pattern of phosphatidic acid, diacylglycerol, CDP-diacylglycerol and phosphatidylglycerol synthesized de novo in rat liver mitochondria. Biochim Biophys Acta 1002: 261-263, 1989.
150. Rytomaa M, Mustonen P, Kinnunen PK. Reversible, nonionic, and pH-dependent association of cytochrome c with cardiolipin-phosphatidylcholine liposomes. J Biol Chem 267: 22243-22248, 1992.
151. Santiago E, Lopez-Moratalla N, Segovia JF. Correlation between losses of mitochondrial ATPase activity and cardiolipin degradation. Biochem Biophys Res Commun 53: 439-445, 1973.
152. Savitha S, Panneerselvam C. Mitochondrial membrane damage during aging process in rat heart: potential efficacy of L-carnitine and dlα lipoic acid. Mech Ageing Dev 127: 349-355, 2006.
153. Schlame M, Beyer K, Hayer-Hartl M, Klingenberg M. Molecular species of cardiolipin in relation to other mitochondrial phospholipids. Is there an acyl specificity of the interaction between cardiolipin and the ADP/ATP carrier? Eur J Biochem 199: 459-466, 1991.
154. Schlame M, Haldar D. Cardiolipin is synthesized on the matrix side of the inner membrane in rat liver mitochondria. J Biol Chem 268: 74-79, 1993.
155. Schlame M, Horvath L, Vigh L. Relationship between lipid saturation and lipid-protein interaction in liver mitochondria modified by catalytic hydrogenation with reference to cardiolipin molecular species. Biochem J 265: 79-85, 1990.
156. Schlame M, Hostetler KY. Solubilization, purification, and characterization of cardiolipin synthase from rat liver mitochondria. Demonstration of its phospholipid requirement. J Biol Chem 266: 22398-22403, 1991.
157. Schlame M, Kelley RI, Feigenbaum A, Towbin JA, Heerdt PM, Schieble T, Wanders RJ, DiMauro S, Blanck TJ. Phospholipid abnormalities in children with Barth syndrome. J Am Coll Cardiol 42: 1994-1999, 2003.
158. Schlame M, Otten D. Analysis of cardiolipin molecular species by high-performance liquid chromatography of its derivative 1,3-bisphosphatidyl-2- benzoyl-sn-glycerol dimethyl ester. Anal Biochem 195: 290-295, 1991.
159. Schlame M, Ren M, Xu Y, Greenberg ML, Haller I. Molecular symmetry in mitochondrial cardiolipins. Chem Phys Lipids 138: 38-49, 2005.
160. Schlame M, Rua D, Greenberg ML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 39: 257-288, 2000.
161. Schlame M, Rustow B. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. Biochem J 272: 589-595, 1990.
162. Schlame M, Shanske S, Doty S, Konig T, Sculco T, DiMauro S, Blanck TJ. Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease. J Lipid Res 40: 1585-1592, 1999.
163. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJ. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51: 634-637, 2002.
164. 2 digestion of cardiolipin bound to bovine cytochrome c oxidase alters both activity and quaternary structure. Biochemistry 38: 14966-14972, 1999.
165. Sen T, Sen N, Tripathi G, Chatterjee U, Chakrabarti S. Lipid peroxidation associated cardiolipin loss and membrane depolarization in rat brain mitochondria. Neurochem Int, 2006.
166. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91: 10771-10778, 1994.
167. Smaal EB, Romijn D, Geurts van Kessel WS, de Kruijff B, de Gier J. Isolation and purification of cardiolipin from beef heart. J Lipid Res 26: 634-637, 1985.
168. Smith MW, Collan Y, Kahng MW, Trump BF. Changes in mitochondrial lipids of rat kidney during ischemia. Biochim Biophys Acta 618: 192-201, 1980.
169. Sotirhos N, Herslof B, Kenne L. Quantitative analysis of phospholipids by 31P-NMR. J Lipid Res 27: 386-392, 1986.
170. Soussi B, Idstrom JP, Schersten T, and Bylund-Fellenius AC. Cytochrome c oxidase and cardiolipin alterations in response to skeletal muscle ischaemia and reperfusion. Acta Physiol Scand 138: 107-114, 1990.
171. Sparagna GC, Johnson CA, McCune SA, Moore RL, Murphy RC. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J Lipid Res 46: 1196-1204, 2005.
172. Suzuki E, Sano A, Kuriki T, Miki T. Improved separation and determination of phospholipids in animal tissues employing solid phase extraction. Biol Pharm Bull 20: 299-303, 1997.
173. Taraschi TF, Ellingson JS, Janes N, Rubin E. The role of anionic phospholipids in membrane adaptation to ethanol. Alcohol Alcohol Suppl 1: 241-245, 1991.
174. Taylor WA, Hatch GM. Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J Biol Chem 278: 12716-12721, 2003.
175. Taylor WA, Xu FY, Ma BJ, Mutter TC, Dolinsky VW, Hatch GM. Expression of monolysocardiolipin acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart. BMC Biochem 3: 9, 2002.
176. Toleikis A, Dzeja P, Praskevicius A, Jasaitis A. Mitochondrial functions in ischemic myocardium. I. Proton electrochemical gradient, inner membrane permeability, calcium transport and oxidative phosphorylation in isolated mitochondria. J Mol Cell Cardiol 11: 57-76, 1979.
177. Toleikis AI, Dagis AI, Prashkiavichius AK. [Effect of myocardial ischemia on the phospholipid composition of cardiac tissue and mitochondria]. Vopr Med Khim 28: 64-67, 1982.
178. Tuominen EK, Wallace CJ, Kinnunen PK. Phospholipid-cytochrome c interaction: evidence for the extended lipid anchorage. J Biol Chem 277: 8822-8826, 2002.
179. Valianpour F, Wanders RJ, Barth PG, Overmars H, van Gennip AH. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients. Clin Chem 48: 1390-1397, 2002.
180. Valianpour F, Wanders RJ, Overmars H, Vaz FM, Barth PG, van Gennip AH. Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment. J Lipid Res 44: 560-566, 2003.
181. Vasdev SC, Biro GP, Narbaitz R, Kako KJ. Membrane changes induced by early myocardial ischemia in the dog. Can J Biochem 58: 1112-1119, 1980.
182. Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol 555: 1-13, 2004.
183. Vorbeck ML, Malewski EF, Erhart LS, Martin AP. Membrane phospholipid metabolism in the isoproterenol-induced cardiomyopathy of the rat. Recent Adv Stud Card Struct Metab 6: 175-181, 1975.
184. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, Barth PG. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 279: 378-382, 2000.
185. Wainwright MS, Kohli R, Whitington PF, Chace DH. Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia-ischemia in newborn rats. Stroke 37: 524-530, 2006.
186. Wolff RL, Combe NA, Entressangles B, Sebedio JL, Grandgirard A. Preferential incorporation of dietary cis-9,cis-12,trans-15 18:3 acid into rat cardiolipins. Biochim Biophys Acta 1168: 285-291, 1993.
187. Xu Y, Kelley RI, Blanck TJ, Schlame M. Remodeling of cardiolipin by phospholipid transacylation. J Biol Chem 278: 51380-51385, 2003.
188. Yamaoka S, Urade R, Kito M. Cardiolipin molecular species in rat heart mitochondria are sensitive to essential fatty acid-deficient dietary lipids. J Nutr 120: 415-421, 1990.
189. Yamaoka S, Urade R, Kito M. Mitochondrial function in rats is affected by modification of membrane phospholipids with dietary sardine oil. J Nutr 118: 290-296, 1988.
190. Yamaoka-Koseki S, Urade R, Kito M. Cardiolipins from rats fed different dietary lipids affect bovine heart cytochrome c oxidase activity. J Nutr 121: 956-958, 1991.
191. Zhang M, Mileykovskaya E, Dowhan W. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J Biol Chem 280: 29403-29408, 2005.
192. Zhang M, Mileykovskaya E, Dowhan W. Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277: 43553-43556, 2002.